Utilizing Small Molecular Inhibitors to Target & Reduce Neuroinflammation

Time: 9:30 am
day: Day Two


  • Focusing on CSRR1 inhibitors to understand how to modulate microglia phenotypes similar to macrophage
  • Understanding why CSFR1 has an improved safety profile to communicate the importance of safety profiles when developing new targets for inflammation
  • Unpicking how to promote neuroprotective functions when developing therapeutics to help improve the next generation of drug development